Godavari Biorefineries receives patent from CNIPA 

China National Intellectual Property Administration (CNIPA) has granted our patent entitled, "5-hydroxy-1,4-naphthalenedione for use in the treatment of cancer”.

This patent covers a novel class of compounds that have exhibited strong inhibitory effects on cancer and cancer stem cells in vitro studies. These compounds have demonstrated significant efficacy against multiple cancer cell types, including breast and prostate cancer.

Anuh Pharma inaugurates new manufacturing block

Anuh Pharma Limited has inaugurated its new manufacturing block at M.I.D.C., Tarapur, Boisar, District Palghar, Maharashtra, India. The new plant is expected to become operational within July, 2025, and upon commencement of operations, it will enhance our existing manufacturing capacity by an added 200 Metric Tons per annum (MT/Annum). Furthermore, the block block includes the installation of an added 40 KL of reactor capacity, which will further strengthen our infrastructure and help to meet growing market demands.